Physical Activity for Health
(MoTrPAC Trial)
Trial Summary
What is the purpose of this trial?
The goal of the Molecular Transducers of Physical Activity Consortium (MoTrPAC) is to assess molecular changes that occur in response to physical activity (PA). To achieve this aim, a mechanistic randomized controlled trial (RCT) is conducted, in which adult study participants are randomized to endurance exercise (EE) training, resistance exercise (RE) training, or no exercise Control for a period of approximately 12 weeks. The overarching hypothesis is that there are discoverable molecular transducers that communicate and coordinate the effects of exercise on cells, tissues, and organs, which may initiate processes ultimately leading to the health benefits of exercise. Because this is a mechanistic trial, the main goal is not a single health-related outcome. Rather, the goal is to generate a resource leading to the generation of a map of the molecular responses to exercise that will be used by the Consortium and by the scientific community at large to generate hypotheses for future investigations of the health benefits of PA.
Will I have to stop taking my current medications?
The trial requires that participants do not have any changes in their chronic-use medications in the last 3 months and excludes those using certain medications like beta blockers, anticoagulants, and chronic oral steroids. If you're on any of these medications, you may need to stop or adjust them before participating.
What evidence supports the effectiveness of the treatment involving endurance and resistance training for cardiovascular health?
Research shows that both endurance and resistance training can improve heart health by increasing physical performance, enhancing quality of life, and reducing risk factors for heart disease. These exercises are safe and beneficial for many patients, including those with heart conditions, when tailored to individual needs and supervised by professionals.12345
Is physical activity, like resistance and endurance training, generally safe for humans?
Physical activity, including resistance and endurance training, is generally safe for most people, but there are some risks, especially for those with certain health conditions. Resistance training can cause adverse events, particularly in people with chronic health issues, and may lead to increased blood pressure in cardiac patients if not properly supervised. However, when done correctly and under medical supervision, it can be as safe as aerobic exercise and beneficial for muscle strength and cardiovascular health.678910
How does the treatment of endurance and resistance training differ from other treatments for improving cardiovascular health?
Endurance and resistance training are unique because they improve cardiovascular health by enhancing the heart's efficiency and increasing the body's ability to use oxygen, unlike other treatments that may focus solely on medication. This type of exercise also helps reduce risk factors like high blood pressure and cholesterol, offering a holistic approach to heart health.1112131415
Research Team
Mike E Miller, PhD
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
Adults aged 18+ who can read and speak English, are willing to consent, and have a BMI between 19-35 kg/m2. Participants should be either sedentary (exercising no more than once a week) or highly active in endurance or resistance training for over a year. Those with certain chronic diseases, recent drug use that affects exercise response, or planning significant weight changes are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are randomized to endurance exercise, resistance exercise, or no exercise control for approximately 12 weeks. Assessments include cardiorespiratory fitness, muscular strength, and body composition.
Follow-up
Participants are monitored for changes in CPET VO2 Peak, isometric knee peak torque, and various blood markers.
Treatment Details
Interventions
- Endurance Training
- Restistance Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
Wake Forest University Health Sciences
Lead Sponsor
Broad Institute of MIT and Harvard
Collaborator
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Stanford University
Collaborator
Broad Institute
Collaborator
Duke University
Collaborator
Emory University
Collaborator
Icahn School of Medicine at Mount Sinai
Collaborator